US biotech Amgen (Nasdaq: AMGN) and Japanese partner Kyowa Kirin (TYO: 4151) announced new results from the ongoing ROCKET ...

It's time for another round of The Market Cap Game Show on Rule Breaker Investing. Remember that market cap calculates a ...

Last week’s significant research news included positive new Phase III data on Tezspire in nasal polyps from Amgen and ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

The US Food and Drug Administration (FDA) has approved Celltrion’s biosimilars referencing Amgen’s bone disease therapy ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

Prevent Blindness, the nation's leading eye health and safety nonprofit organization, will host the 14th Annual Prevent Blindness Focus on Eye Health Summit on May 14, 2025, as a free, interactive ...

Patrick Kielty and his family have been left heartbroken by the death of his mother, Mary Keilty - who passed away over the ...

About the ROCKET Phase 3 Program ROCKET is a comprehensive, global Phase 3 clinical trial program comprised of eight studies intended to establish the safety and efficacy profile of rocatinlimab in ...